MARGen Clinic, 18006 Granada, Spain.
Int J Mol Sci. 2022 Aug 2;23(15):8562. doi: 10.3390/ijms23158562.
Maternal-to-zygotic transition (MZT) of the control of early post-fertilization development is a key-event conditioning the fate of the future embryo, fetus and newborn. Because of the relative paucity of data concerning human embryos, due to ethical concerns and the poor availability of human embryos donated for research, most data have to be derived from animal models, among which those obtained using mouse embryos are most prevalent. However, data obtained by studies performed in non-mammalian specie can also provide useful information. For this reason, this review focuses on similarities and differences of MZT control mechanisms in humans and other species, with particular attention to the mouse. A number of molecular pathways controlling MZT in mice and humans are compared, pointing out those that could be at the origin of further focused experimental studies and the development of new diagnostic tools based on the translational medicine principles. Data concerning possible candidate molecules to be included in these studies are identified.
母源到合子的转变(MZT)控制着早期受精后胚胎的发育,是决定未来胚胎、胎儿和新生儿命运的关键事件。由于涉及人类胚胎的数据相对较少,由于伦理问题和缺乏用于研究的人类胚胎捐赠,大多数数据必须来自动物模型,其中最常见的是使用小鼠胚胎获得的数据。然而,在非哺乳动物物种中进行的研究获得的数据也可以提供有用的信息。出于这个原因,本综述重点关注人类和其他物种的 MZT 控制机制的异同,特别关注小鼠。比较了控制小鼠和人类 MZT 的一些分子途径,指出了那些可能是进一步集中进行实验研究以及基于转化医学原则开发新诊断工具的起源。确定了可能包含在这些研究中的候选分子的数据。